More recently, pre-clinical studies have shown AMPK having some involvement in others cancers, including melanoma [11, 48-52], breast cancer [53-56], prostate cancer [57, 58], ovarian cancer [59, 60] and leukemia's [61]. Here, PRKAA2 is linked to prostate cancer.